FAP regimen

chemotherapy protocol containing UFT, doxorubicin, & cisplatin; used in treatment of patients with advanced gastric cancer

Networked: 7 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - FAP regimen: 7
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - FAP regimen: 7
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - FAP regimen: 7
Inorganic Chemicals: 9
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Doxorubicin: 35390
        FAP regimen: 7
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        FAP regimen: 7
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        FAP regimen: 7
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidinones: 71
      - Uracil: 1493
        Fluorouracil: 26711
        Tegafur: 1507
        FAP regimen: 7
        FAP regimen: 7

Experts

1.	Huang, Fei-Zhou: 1 article (08/2013)
2.	Jiang, Xian-Zhen: 1 article (08/2013)
3.	Liu, Xun-Yang: 1 article (08/2013)
4.	Nie, Wan-Pin: 1 article (08/2013)
5.	Wang, Chang-Fa: 1 article (08/2013)
6.	Wang, Ya-Qin: 1 article (08/2013)
7.	Asaka, Shinichi: 1 article (07/2008)
8.	Isohata, Noriyuki: 1 article (07/2008)
9.	Katsube, Takao: 1 article (07/2008)
10.	Konno, Soichi: 1 article (07/2008)

Related Diseases

1.	Neoplasms (Cancer) 09/15/1983 - "This FAP regimen is useful in the treatment of advanced esophageal tumors."
2.	Esophageal Neoplasms (Esophageal Cancer) 09/01/1995 - "This FAP regimen is suspected to be useful chemotherapy for advanced esophageal cancer." 07/01/2008 - "This study was performed to assess the usefulness and safety of neoadjuvant chemotherapy utilizing the FAP regimen consisting of 5-fluorouracil, cisplatin and adriamycin for the treatment of highly advanced esophageal cancer. "
3.	Carcinoma (Carcinomatosis) 01/01/1989 - "A FAP regimen appears to exert a marginal effect in advanced prostatic carcinoma." 12/01/1987 - "Phase II trial of combined 5-fluorouracil plus doxorubicin plus cisplatin (FAP regimen) in advanced gastric carcinoma."
4.	Stomach Neoplasms (Stomach Cancer) 10/01/1995 - "In the preclinical study of a new combination therapy for gastric cancer, dFTP, consisting of doxifluridine (5'-DFUR), pirarubicin (THP) and cisplatin (DDP) as a modification of conventional FAP regimen (5-fluorouracil+Adriamycin+DDP), we compared antitumor and toxic effects of two sequential treatment schedules, single injection of DDP before or after 4 daily administrations of 5'-DFUR, on 5 strains of human gastric cancer bearing nude mice. "
5.	Hepatocellular Carcinoma (Hepatoma) 08/01/2013 - "The combined use of methyl jasmonate and the FAP regimen might be a novel strategy for overcoming the multidrug resistance often observed in hepatocellular carcinoma." 08/01/2013 - "Multidrug resistant H22 (H22/FAP) hepatocellular carcinoma cells were produced in vitro by continuous exposure to increasing doses of doxorubicin, cisplatin and 5-fluorouracil (FAP regimen). "

Related Drugs and Biologics

1.	Fluorouracil (Carac)
2.	Doxorubicin (Adriamycin)
3.	Cisplatin (Platino)
4.	pirarubicin
5.	doxifluridine
6.	methyl jasmonate

Related Therapies and Procedures

1.	Neoadjuvant Therapy
2.	Therapeutics
3.	Drug Therapy (Chemotherapy)